Neurological Technologies Inc., of Richmond, Calif., appointed David Levy vice president of clinical development.
Novagali Pharma, of Evry, France, appointed Jerome Martinez chairman and Alain Munoz president of the supervisory board.
Odyssey Pharmaceuticals Inc., of Hanover, N.J., appointed Thomas Wicks vice president of regulatory affairs.
OXIS International Inc., of Portland, Ore., appointed Marvin Hausman to its board.
Phenomix Corp., of San Diego, appointed Hans-Peter Guler vice president of clinical development.
Plexus Corp., of Neenah, Wis., appointed Ralf Boer to its board.
Pluristem Life Systems Inc., of Haifa, Israel, retained stem cell expert Avraham Treves to collaborate with the company.
Portola Pharmaceuticals Inc., of South San Francisco, appointed Carol Olson executive vice president.
Proneuron Biotechnologies, of Los Angeles, appointed Marca Sipski to the Procord study steering committee.
Radiologix Inc., of Dallas, appointed John Gunn to its board.
Rosalind Franklin University of Medicine and Science in North Chicago, Ill., elected Ruth Rothstein as chair of its board.
Saegis Pharmaceuticals Inc., of Half Moon Bay, Calif., appointed Jean-Jacques Bienaime to its board.
Sangamo BioSciences Inc., of Point Richmond, Calif., appointed Dale Ando vice president, therapeutic development and chief medical officer.
Savient Pharmaceuticals Inc., of East Brunswick, N.J., appointed Lawrence Gyenes senior vice president, chief financial officer and treasurer.
Signet Laboratories Inc., of Dedham, Mass., appointed Peggy Taylor vice president of production and development, and Arnold Kana director of production and manufacturing.
Sirna Therapeutics Inc., of Boulder, Colo., appointed Martin Schmieg senior vice president and chief financial officer.
Sofinnova Ventures in San Francisco, hired Nicola Campbell as a life science partner.
Solexa Ltd., of Cambridge, UK, appointed John West CEO.
Somaxon Pharmaceuticals Inc., of San Diego, appointed Timothy Hsu vice president, clinical development.
Somnia Inc., of New Rochelle, N.Y., appointed Anthony Guglielmi director of corporate communications.
Synovis Life Technologies Inc., of St. Paul, Minn., appointed Richard Kramp president and chief operating officer.
TAP Pharmaceutical Products Inc., of Lake Forest, Ill., appointed Alan MacKenzie president.
Telik Inc., of Palo Alto, Calif., appointed Herwig von Morze to its board.
Teranode Corp., of Seattle, appointed Matthew Shanahan chief marketing officer.
The Global Alliance for TB Drug Development, of New York, appointed Zhenkun Ma head of research.
ThinkEquity Partners in San Francisco, appointed Stuart Pulvirent managing director and senior research analyst focused on nanotechnology and life sciences.
Third Wave Technologies Inc., of Madison, Wis., appointed Lionel Sterling to its board.
TransMolecular Inc., of Birmingham, Ala., appointed Randall Riggs vice president of business development.
Vertex Pharmaceuticals Inc., of Cambridge, Mass., appointed Matthew Emmens to its board.
Viral Genetics Inc., of Azusa, Calif., appointed Jocelyn Elders to its scientific and medical advisory board.
VistaGen Therapeutics Inc., of Burlingame, Calif., appointed Lynda Sutton director and vice president, regulatory affairs, and Shawn Singh chief operating officer and general counsel.